Geode Capital Management, LLC Janux Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 467,547 shares of JANX stock, worth $19.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

467,547

Previous 408,190 14.54%

Holding current value

$19.6 Million

Previous $4.38 Million 301.99%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$7.93 - $49.75 $470,701 - $2.95 Million	59,357 Added 14.54%	467,547 $17.6 Million
Q4 2023 Feb 13, 2024	BUY	$5.85 - $11.7 $125,108 - $250,216	21,386 Added 5.53%	408,190 $4.38 Million
Q3 2023 Nov 13, 2023	BUY	$9.56 - $14.0 $91,575 - $134,106	9,579 Added 2.54%	386,804 $3.9 Million
Q2 2023 Aug 11, 2023	BUY	$11.08 - $15.92 $250,851 - $360,428	22,640 Added 6.38%	377,225 $4.48 Million
Q1 2023 May 15, 2023	BUY	$11.25 - $22.21 $166,365 - $328,441	14,788 Added 4.35%	354,585 $4.29 Million

Q4 2022 Feb 13, 2023	BUY	$11.1 - $18.26 $58,563 - $96,339	5,276 Added 1.58%	339,797 $4.48 Million
Q3 2022 Nov 14, 2022	BUY	$10.82 - $16.84 $550,748 - $857,172	50,901 Added 17.95%	334,521 $4.53 Million
Q2 2022 Aug 12, 2022	BUY	$9.52 - $15.65 $79,863 - $131,287	8,389 Added 3.05%	283,620 $3.46 Million
Q1 2022 May 13, 2022	BUY	$13.24 - $20.24 $724,280 - $1.11 Million	54,704 Added 24.81%	275,231 $3.95 Million
Q4 2021 Feb 11, 2022	BUY	$15.44 - $27.32 $133,509 - $236,236	8,647 Added 4.08%	220,527 $4.35 Million
Q3 2021 Nov 12, 2021	BUY	$20.7 - $34.69 $3.93 Million - $6.59 Million	189,863 Added 862.35%	211,880 $4.58 Million
Q2 2021 Aug 13, 2021	BUY	$18.58 - $25.37 $409,075 - $558,571	22,017 New	22,017 $549,000

Others Institutions Holding JANX

# of Institutions

123

Shares Held

25.3M

Call Options Held

92K

Put Options Held

161K

View Full List

About Janux Therapeutics, Inc.

Ticker JANX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,663,000
Market Cap $1.75B
Description
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...

More about JANX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Janux Therapeutics, Inc. Transaction History